Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Microbicides
100%
Papillomavirus
100%
Infectivity
27%
Human Papillomavirus
27%
Microbicidal
22%
Human Papillomavirus 11
22%
Neutralizing Monoclonal Antibody
16%
Genital
16%
In Vitro Model
11%
Papillomavirus Infections
11%
Animal Model System
11%
Skin Cancer
11%
Vaginal Cancer
11%
Focus Formation
11%
C127 Cells
11%
Cervical Cancer
11%
Causative Agents
11%
Human Papillomavirus Types
11%
BPV1
11%
Penile Cancer
11%
Xenograft Model
11%
Common Mechanisms
5%
Positive Control
5%
Virion
5%
Renal Capsule
5%
Assay System
5%
Human Detection
5%
Athymic Mice
5%
Human Papillomavirus DNA
5%
In Vitro Assay
5%
In Vivo Model
5%
Transvaginal
5%
Virus Binding
5%
Epithelial Cells
5%
Precursor Lesions
5%
Virus
5%
In Vivo Efficacy
5%
Transient Infection
5%
In Vitro Systems
5%
Human Foreskin
5%
Incidental
5%
Xenograft
5%
Oral Cancer
5%
PCR Detection
5%
A431
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antimicrobial Agent
100%
Papillomaviridae
100%
Infection
50%
Human Papillomavirus
44%
Human Papillomavirus Type 11
22%
Monoclonal Antibody
16%
Leporidae
16%
Sexually Transmitted Disease
16%
Papillomavirus Infection
11%
Virus
11%
Vagina Cancer
11%
Bovine Papillomavirus Type 1
11%
Penis Cancer
11%
Uterine Cervix Cancer
11%
Skin Cancer
11%
Antivirus Agent
5%
Nude Mouse
5%
Sulfate
5%
Enzyme-Linked Immunosorbent Assay
5%
Mouth Cancer
5%
Messenger RNA
5%
Immunology and Microbiology
Antimicrobial Agent
100%
Papillomaviridae
100%
Infection
55%
In Vitro
45%
Wart Virus
38%
Infectious Disease
29%
Human Papillomavirus Type 11
20%
Monoclonal Antibody
15%
Xenograft
14%
Leporidae
14%
Bovine Papillomavirus Type 1
10%
Virus
5%
Virus Attachment
5%
Nude Mouse
5%
Cell Line
5%
Viral Entry
5%